Genomic Analysis of Inflammatory Breast Cancer
Author Information
Author(s): Ismahane Bekhouche, Pascal Finetti, José Adelaïde, Anthony Ferrari, Carole Tarpin, Emmanuelle Charafe-Jauffret, Colette Charpin, Gilles Houvenaeghel, Jocelyne Jacquemier, Ghislain Bidaut, Daniel Birnbaum, Patrice Viens, Max Chaffanet, François Bertucci
Primary Institution: Marseille Cancer Research Center (CRCM), UMR891 Inserm, Institut Paoli-Calmettes (IPC), Marseille, France
Hypothesis
What are the genomic differences between inflammatory breast cancer (IBC) and non-inflammatory breast cancer (nIBC)?
Conclusion
The study identifies a higher genomic instability in inflammatory breast cancer and provides a list of candidate genes that may contribute to its aggressiveness.
Supporting Evidence
- The study analyzed 197 breast cancer samples, including 63 inflammatory breast cancers.
- Integrated analysis identified 24 potential candidate genes specific to inflammatory breast cancer.
- Genomic profiles of inflammatory breast cancers showed higher complexity compared to non-inflammatory breast cancers.
Takeaway
Researchers looked at the DNA of breast cancer samples to find out why inflammatory breast cancer is more aggressive, and they found some important genes that could help in treatment.
Methodology
The study used high-resolution array-comparative genomic hybridization and whole-genome microarrays to analyze genomic imbalances and mRNA expression profiles.
Potential Biases
Potential bias due to the selection of control samples and the retrospective nature of the study.
Limitations
The study is limited by the relatively small sample size of inflammatory breast cancer cases.
Participant Demographics
The study included 197 patients with invasive adenocarcinomas, comprising 63 IBCs and 134 nIBCs.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website